Examine the rationale and implementation strategy of India's nationwide HPV vaccination campaign. How does it address gender-specific health vulnerabilities?

Q. Examine the rationale and implementation strategy of India's nationwide HPV vaccination campaign. How does it address gender-specific health vulnerabilities? (15 marks, 250-350 words)

Cervical cancer is the second most common cancer among Indian women, causing over 1.2 lakh new cases annually (WHO GLOBOCAN 2022) [1]. India's nationwide HPV vaccination campaign, launched on 28 February 2026 from Ajmer, Rajasthan, converts this preventable burden into a primary-prevention agenda within the Universal Immunization Programme (UIP).

Rationale - Disease burden: nearly 80,000 deaths yearly, largely from late diagnosis in the absence of population-wide screening [1]. - Scientific basis: a single dose of the quadrivalent vaccine offers 93–100% protection against oncogenic HPV types 16 and 18 [1]. - Institutional endorsement: introduction followed NTAGI recommendation, aligning India with 160+ countries that already vaccinate nationally [1]. - Cost logic: prevention is far cheaper than tertiary oncology care, easing out-of-pocket health expenditure.

Implementation strategy - Coverage: about 1.15–1.2 crore girls aged 14 every year, across all 36 States/UTs, free of cost at government facilities [1][2]. - School-based delivery through classes 5–10, with health facility, mobile and community outreach for out-of-school girls [1]. - Platform leverage: delivered through Ayushman Arogya Mandirs, CHCs and district hospitals, using UIP's existing cold chain and the ASHA–ANM–CHO frontline network [2]. - Demand generation: radio jingles, posters and digital campaigns to counter hesitancy around adolescent vaccination [2].

Addressing gender-specific vulnerabilities - Targets a cancer that is exclusively borne by women, correcting the historic neglect of female-specific non-communicable diseases. - School-based delivery reaches rural and low-literacy households where women's reproductive health needs are deprioritised within the family [1]. - Free provision removes the intra-household bias in spending on daughters' health. - Protects adolescent girls before exposure, an age group otherwise outside routine health contact.

The campaign thus links epidemiological evidence, an existing delivery backbone and gender equity into one intervention. Its success will depend on sustaining second-year cohorts, tracking out-of-school girls and pairing vaccination with screening for older women. Anchored in Article 47's duty to raise public health standards and SDG 3.4 on reducing premature NCD mortality, it marks a decisive step toward WHO's cervical cancer elimination goal.

(~320 words)

Sources: 1. Prime Minister Shri Narendra Modi Launches Nationwide HPV Vaccination Drive for 14-Year-Old Girls from Ajmer, Rajasthan, PIB (28 Feb 2026) — launch date and venue, disease burden, vaccine efficacy, NTAGI recommendation, 160+ countries, target cohort, school-based and outreach delivery 2. Update on Immunization Programme and Pandemic Preparedness, Ministry of Health and Family Welfare, PIB (21 July 2026) — beneficiary numbers across 36 States/UTs, Ayushman Arogya Mandir delivery platform and frontline workforce, awareness campaign